What Are Bioactive Collagen Peptides? A Guide to VERISOL® Collagen Peptides

Written by Dr. Ilma Imtiaz

Quick answer: Verisol® is a patented, clinically studied form of bioactive bovine collagen peptides produced by GELITA that has been investigated for supporting visible skin health, including skin elasticity, hydration, wrinkle appearance, cellulite, and nail strength, at relatively low daily doses (2.5 g/day).

Why Collagen Supplementation Matters

Collagen is the main structural protein in the dermis, providing the skin with its firmness, elasticity, and resilience (1). From our mid-20s, collagen production naturally begins to decline, while existing collagen is progressively affected by factors such as ultraviolet (UV) exposure, pollution, smoking, and hormonal changes, including the menopausal transition. Over time, these changes contribute to thinner, less elastic skin, fine lines, wrinkles, and visible changes in skin texture and contour (2,3). Studies of chronologically aged skin show that dermal fibroblasts produce less collagen types I and III and become less responsive to the mechanical signals that normally stimulate repair 1. As a result, the skin's ability to maintain and renew its extracellular matrix gradually declines with age.

Oral collagen supplementation has therefore emerged as a nutritional strategy to support the skin from within. Randomized controlled trials and systematic reviews have reported improvements in skin hydration, elasticity, and wrinkle appearance with hydrolyzed collagen and low-molecular-weight collagen peptides (4,5). Not all collagen ingredients are the same, however. Differences in manufacturing, peptide composition, and clinical testing mean that evidence for one collagen ingredient cannot automatically be applied to another.

What Are Bioactive Collagen Peptides?

Bioactive collagen peptides (BCPs) are specific low-molecular-weight collagen peptide fractions produced through controlled enzymatic hydrolysis (6). Unlike generic collagen powders, BCPs are manufactured to have defined amino acid sequences and molecular weight profiles that are designed to be efficiently absorbed and biologically active.

BCPs such as Verisol® are standardized to specific peptide profiles that have been evaluated in randomized, double-blind, placebo-controlled clinical trials for outcomes including skin elasticity, hydration, wrinkle appearance, cellulite, and nail strength (6,7). Rather than acting solely as a source of amino acids, these peptides are thought to function as signaling molecules that interact with dermal fibroblasts, helping support the body's natural production of collagen and elastin within the extracellular matrix while also providing the amino acid building blocks required for collagen synthesis.

How Are Bioactive Collagen Peptides Thought to Work?

Although research into their exact mechanisms continues to evolve, current evidence suggests bioactive collagen peptides work through more than one pathway. After digestion and absorption, specific collagen-derived peptides are thought to distribute to different tissues throughout the body depending on their peptide profile 8. Verisol® peptides are believed to preferentially accumulate in the dermis, where they may act as biological signals that support fibroblast activity and the skin's normal collagen-producing processes. At the same time, they provide amino acids such as glycine, proline, and hydroxyproline that are required for collagen synthesis (9).

This proposed dual mechanism distinguishes bioactive collagen peptides from the idea that collagen supplements simply provide dietary protein. While mechanistic research is ongoing, the consistency of findings across laboratory studies and human clinical trials provides biological plausibility for the improvements reported in skin-related outcomes.

What Is Verisol®?

Verisol® is a patented, branded ingredient consisting of specific bioactive bovine collagen peptides produced by GELITA using a controlled enzymatic hydrolysis process. This manufacturing process produces peptides with a defined molecular weight distribution and peptide profile that have been repeatedly evaluated in human clinical studies.

Across published randomized controlled trials, Verisol® has most commonly been administered orally at a daily dose of 2.5 g, dissolved in water or another beverage and taken once daily over periods ranging from 8 weeks to 6 months (6,7). These ingredient-specific studies have investigated its effects on visible skin parameters including skin elasticity, hydration, wrinkle appearance, cellulite, and nail strength.

What Does the Clinical Research Show?

The evidence supporting Verisol® is built primarily on randomized, double-blind, placebo-controlled clinical trials conducted in healthy adult women using a daily dose of 2.5 g (7,10-14).

• Skin Elasticity and Wrinkle Appearance

Several clinical trials have investigated Verisol® for visible signs of skin aging.

• In one randomized trial involving 69 women aged 35–55 years, Verisol® supplementation significantly improved skin elasticity after both 4 and 8 weeks compared with placebo, with some benefits still detectable four weeks after supplementation ceased (14).

• In a landmark study of 114 women aged 45–65 years, daily supplementation with 2.5 g Verisol® for 8 weeks reduced eye wrinkle volume by approximately 20% compared with placebo. Researchers also reported increases in dermal procollagen I (approximately 65%) and elastin (approximately 18%), suggesting support for the skin's extracellular matrix (6).

• A more recent eight-week randomized controlled trial involving 66 women aged 35–55 years reported improvements in skin hydration after four weeks, with further improvements in hydration, elasticity, and wrinkle appearance after eight weeks compared with placebo (7).

A notable strength of these studies is the use of objective assessment methods, including 3D wrinkle imaging, cutometry for elasticity, corneometry for hydration, and skin biopsies, rather than relying solely on participant questionnaires.

• Cellulite and Nail Health

Beyond facial skin, Verisol® has also been investigated for cellulite morphology and nail health.

In a six-month randomized, double-blind, placebo-controlled trial involving 105 women aged 25–50 years, supplementation with 2.5 g Verisol® was associated with improvements in cellulite appearance, reductions in skin waviness, and increases in dermal density measured by ultrasound compared with placebo (13).

Another clinical study investigating brittle nails reported improvements in nail growth, reductions in chipped and cracked nails, and improvements in nail appearance following six months of supplementation (10). Some participants continued to report benefits four weeks after supplementation had ceased.

Suggested Dose

Most Verisol® clinical studies have used a once-daily dose of 2.5 g.

Published studies have generally reported improvements in skin hydration and elasticity after approximately 4–8 weeks of daily supplementation, while studies investigating cellulite and nail outcomes have typically continued supplementation for 3–6 months (6,7,10,13,14).

Typical study protocols include:

• Skin elasticity, hydration, and wrinkle appearance: 2.5 g once daily for at least 8–12 weeks.

• Cellulite and dermal structure: 2.5 g once daily for 3–6 months.

• Nail strength and growth: 2.5 g once daily for approximately 6 months.

Who Might Consider Verisol®?

Based on the published clinical evidence, Verisol® may be suitable for adults looking to support visible skin health as part of a broader skincare and healthy aging routine.

It may be particularly relevant for:

• Adults noticing age-related changes in skin elasticity, hydration, wrinkle appearance, or cellulite.

• Individuals with brittle or fragile nails who are interested in nutritional approaches to support nail strength and growth.

• People already following comprehensive skin care practices, including sun protection, a balanced diet, and topical skincare, who wish to incorporate an ingestible collagen peptide with ingredient-specific human clinical research.

Because Verisol® is derived from bovine type I collagen, it is most suitable for individuals who consume bovine-derived ingredients. Those following pescatarian diets may prefer marine-derived collagen ingredients such as Verisol® Marine. Individuals with known hypersensitivity to bovine collagen or related proteins should avoid its use.

Safety and Side Effects

Hydrolyzed collagen peptides have an extensive history of use and are generally well tolerated. Across published Verisol® clinical studies, daily supplementation with 2.5 g for periods ranging from 8 weeks to 6 months has not been associated with serious adverse events (6,7,10,13,14).

Occasional gastrointestinal symptoms such as fullness or mild digestive discomfort have been reported across the broader collagen literature, particularly with higher doses, but these effects are typically uncommon.

As with any dietary supplement, individuals who are pregnant or breastfeeding, have complex medical conditions, or have known allergies to bovine proteins should consult their healthcare practitioner before use.

How Is Verisol® Different from Regular Collagen Supplements?

Several factors distinguish Verisol® from generic collagen supplements.

Ingredient standardization. Verisol® is a patented ingredient with a defined peptide profile that has been investigated in ingredient-specific human clinical trials. In contrast, generic collagen supplements may contain different peptide mixtures, collagen sources, molecular weights, and manufacturing processes.

Studied dose. Most Verisol® clinical studies have used a daily dose of 2.5 g, which is lower than many generic collagen products. A larger serving size does not necessarily indicate a better product if the ingredient itself has not been clinically evaluated.

Quality of the evidence. Verisol® has been investigated in multiple randomized, double-blind, placebo-controlled clinical trials, whereas many generic collagen products rely on evidence from broader collagen research that may not reflect the specific ingredient or formulation being sold.

Take Home Message

Bioactive collagen peptides represent a more targeted category of collagen ingredients than generic collagen powders. Rather than simply providing amino acids, specific peptide profiles such as Verisol® have been investigated for their potential biological activity and their ability to support the skin's normal collagen-producing processes.

Among currently available collagen ingredients, Verisol® is one of the few supported by ingredient-specific randomized clinical trials evaluating visible skin health outcomes. While no single ingredient is a substitute for healthy lifestyle practices, understanding the ingredient, the studied dose, and the quality of the supporting evidence can help both consumers and practitioners make more informed decisions when selecting a collagen supplement.

FAQs

Is VERISOL® the same as collagen peptides?

Not exactly. VERISOL® is a specific type of hydrolyzed collagen peptide produced using GELITA's patented manufacturing process to generate a defined peptide profile. While generic collagen peptides are also hydrolyzed, their peptide composition can vary between manufacturers and may not have been evaluated in the same ingredient-specific clinical studies as VERISOL®.

What is the difference between bioactive collagen peptides and hydrolyzed collagen?

Hydrolyzed collagen refers to collagen that has been broken down into smaller peptides for easier digestion and absorption. Bioactive collagen peptides are a specific subset of hydrolyzed collagen that have defined peptide profiles and have been investigated for targeted biological activities. 

How much VERISOL® should I take per day?

Most published clinical studies investigating VERISOL® from bovine sources for skin health have used a daily dose of 2.5 g (2,500 mg). This dose has been evaluated in randomized, placebo-controlled clinical trials investigating skin elasticity, hydration, wrinkle appearance, cellulite, and nail strength. At present, there is no consistent evidence that higher daily doses provide additional benefits for these skin-related outcomes.

Is VERISOL® vegan?

No. Standard VERISOL® is derived from bovine collagen, while VERISOL®-F is derived from fish collagen. 

How long does VERISOL® take to show results?

The timeframe depends on the outcome being measured. In published clinical studies, improvements in skin hydration and elasticity have generally been observed after 8–12 weeks of daily supplementation, while studies investigating cellulite and nail strength have typically continued for 3–6 months. Because collagen remodeling is a gradual biological process, VERISOL® is intended for consistent daily use rather than immediate results.

What is VERISOL®-F and how is it different from VERISOL®?

VERISOL®-F is the marine (fish-derived) version of VERISOL® produced by GELITA. It is intended for people who prefer a fish-derived collagen ingredient for dietary, cultural, or personal reasons. 

References

1. Ivaskiene T, Viskelis J, Streimikyte P, Savickaitė M, Mobasheri A, Kaspute G. Collagen supplementation and regenerative health: advances in biomarker detection and smart material integration. Front Nutr. 2025;12:1716166. doi:10.3389/fnut.2025.1716166

2. Tuli HS, Garg VK, Mehta JK, et al. Licorice (Glycyrrhiza glabra L.)-derived phytochemicals target multiple signaling pathways to confer oncopreventive and oncotherapeutic effects. Onco Targets Ther. 2022;15:1419-1448. doi:10.2147/OTT.S366630

3. Reilly DM, Lozano J. Skin collagen through the lifestages: importance for skin health and beauty. Plast Aesthet Res. 2021;8:2. doi:10.20517/2347-9264.2020.153

4. Marzec WZ, Marzec MT, Łakoma A, et al. The effects of oral collagen supplementation on skin aging. Quality in Sport. 2024;20:53977. doi:10.12775/QS.2024.20.53977

5. Pu SY, Huang YL, Pu CM, et al. Effects of oral collagen for skin anti-aging: a systematic review and meta-analysis. Nutrients. 2023;15(9):2080. doi:10.3390/nu15092080

6. Proksch E, Schunck M, Zague V, Segger D, Degwert J, Oesser S. Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis. Skin Pharmacol Physiol. 2014;27(3):113-119. doi:10.1159/000355523

7. Proksch E, Zdzieblik D, Oesser S. The oral intake of specific bovine-derived bioactive collagen peptides has a stimulatory effect on dermal matrix synthesis and improves various clinical skin parameters. Cosmetics. 2025;12(2):79. doi:10.3390/cosmetics12020079

8. Virgilio N, Schön C, Mödinger Y, et al. Absorption of bioactive peptides following collagen hydrolysate intake: a randomized, double-blind crossover study in healthy individuals. Front Nutr. 2024;11:1416643. doi:10.3389/fnut.2024.1416643

9. Yazaki M, Ito Y, Yamada M, et al. Oral ingestion of collagen hydrolysate leads to the transportation of highly concentrated Gly-Pro-Hyp and its hydrolyzed form of Pro-Hyp into the bloodstream and skin. J Agric Food Chem. 2017;65(11):2315-2322. doi:10.1021/acs.jafc.6b05679

10. Hexsel D, Zague V, Schunck M, Siega C, Camozzato FO, Oesser S. Oral supplementation with specific bioactive collagen peptides improves nail growth and reduces symptoms of brittle nails. J Cosmet Dermatol. 2017;16(4):520-526. doi:10.1111/jocd.12393

11. Oesser S, Schunk M, Proksch E. Positive effect of fish-derived bioactive collagen peptides on skin health. Int J Nutraceuticals Funct Foods Novel Foods. 2020;1:127-133.

12. Oesser S. The oral intake of specific bioactive collagen peptides has a positive effect on hair thickness. Int J Nutraceuticals Funct Foods Novel Foods. 2020;1:134-138.

13. Schunck M, Zague V, Oesser S, Proksch E. Dietary supplementation with specific collagen peptides has a body mass index-dependent beneficial effect on cellulite morphology. J Med Food. 2015;18(12):1340-1348. doi:10.1089/jmf.2015.0022

14. Proksch E, Segger D, Degwert J, Schunck M, Zague V, Oesser S. Oral supplementation of specific collagen peptides has beneficial effects on human skin physiology: a double-blind, placebo-controlled study. Skin Pharmacol Physiol. 2014;27(1):47-55. doi:10.1159/000351376

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.